Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure.

Sylwia Szeląg-PieniekStefan OswaldMariola PostJoanna Łapczuk-RomańskaMarek DroździkMateusz Kurzawski

Published in: Pharmacological reports : PR (2021)

Altered hepatic expression of drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure may result in changes of drug pharmacokinetics in that group of patients.

Keyphrases

liver failure
hepatitis b virus
adverse drug
end stage renal disease
newly diagnosed
prognostic factors
electronic health record